SER Stock Summary and Trading Ideas (Serina Therapeutics | AMEX:SER)

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics trades on the AMEX stock market under the symbol SER.

As of May 9, 2024, SER stock price declined to $8.80 with 15,164 million shares trading.

SER has a market cap of $22.01 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that SER belongs to (by Net Assets): VTI, VXF.

SER support price is $8.34 and resistance is $9.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SER stock will trade within this expected range on the day.